Possible rheumatoid arthritis subtypes in terms of rheumatoid factor, depression, diagnostic delay and emotional expression: An exploratory case-control study

Arthritis Research and Therapy

Volumn 15, Issue 2, 2013, Pages

  Tillmann, Taavi ^a,b   Krishnadas, Rajeev ^b   Cavanagh, Jonathan ^b   Petrides, K V ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RHEUMATOID FACTOR;

ADULT; ARTICLE; ASSERTIVENESS; CASE CONTROL STUDY; CONTROLLED STUDY; DELAYED DIAGNOSIS; DEPRESSION; EMOTIONAL INTELLIGENCE; EMOTIONALITY; EMPATHY; FEMALE; HUMAN; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; RISK FACTOR; SCORING SYSTEM; SELF ESTEEM; STRESS MANAGEMENT; WELLBEING; BLOOD; CROSS-SECTIONAL STUDY; MIDDLE AGED; PSYCHOLOGY;

ADULT; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DELAYED DIAGNOSIS; DEPRESSION; EMOTIONAL INTELLIGENCE; FEMALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RHEUMATOID FACTOR;

EID: 84875132533     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4204     Document Type: Article

References (83)

1. Aho K, Heliövaara M. Risk factors for rheumatoid arthritis. Ann Med 2004, 36:242-251. 10.1080/07853890410026025, 15224650.
2. Symmons DP, Bankhead CR, Harrison BJ, Brennan P, Barrett EM, Scott DG, Silman AJ. Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum 1997, 40:1955-1961. 10.1002/art.1780401106, 9365083.
3. Walker JG, Littlejohn GO, McMurray NE, Cutolo M. Stress system response and rheumatoid arthritis: a multilevel approach. Rheumatology 1999, 38:1050-1057. 10.1093/rheumatology/38.11.1050, 10556255.
4. Cutolo M, Straub RH. Stress as a risk factor in the pathogenesis of rheumatoid arthritis. Neuroimmunomodulation 2006, 13:277-282. 10.1159/000104855, 17709949.
5. Feigenbaum SL, Masi AT, Kaplan SB. Prognosis of rheumatoid arthritis. Am J Med 1979, 66:377-384. 10.1016/0002-9343(79)91055-6, 433943.
6. Latman NS, Walls R. Personality and stress: an exploratory comparison of rheumatoid arthritis and osteoarthritis. Arch Phys Med Rehab 1996, 77:796-800.
7. Rimon R, Laakso R. Life stress and rheumatoid arthritis. Psychother Psychosom 1985, 43:38-43. 10.1159/000287856, 3975335.
8. Marcenaro M, Prete C, Badini A, Sulli A, Magi E, Cutolo M. Rheumatoid arthritis, personality, stress response style, and coping with illness. A preliminary survey. Ann N Y Acad Sci 1999, 876:419-425. 10.1111/j.1749-6632.1999.tb07666.x, 10415637.
9. Sun J, Wang S, Zhang J-Q, Li W. Assessing the cumulative effects of stress: the association between job stress and allostatic load in a large sample of Chinese employees. Work Stress 2007, 21:333-347.
10. Kubzansky LD, Kawachi I, Sparrow D. Socioeconomic status, hostility, and risk factor clustering in the Normative Ageing Study: any help from the concept of allostatic load?. Ann Behav Med 1999, 21:330-338. 10.1007/BF02895966, 10721441.
11. Tyrka AR, Wier LM, Price LH, Rikhye K, Ross NS, Anderson GM, Wilkinson CW, Carpenter LL. Cortisol and ACTH response to the Dex/CRH Test: Influence of temperament. Horm Behav 2008, 54:518-525.
12. Oswald LM, Zandi P, Nestadt G, Potash JB, Kalaydjian AE, Wand GS. Relationship between cortisol responses to stress and personality. Neuropsychopharmacology 2006, 31:1583-1591. 10.1038/sj.npp.1301012, 16407895.
13. Moldofsky H, Rothman AI. Personality, disease parameters and medication in rheumatoid arthritis. J Chronic Dis 1971, 24:363-372. 10.1016/0021-9681(71)90136-6, 5136233.
14. Gallagher DJ. Extraversion, neuroticism and appraisal of stressful academic events. Pers Indiv Differ 1990, 11:1053-1057.
15. Anderson KO, Bradley LA, Young LD, McDaniel LK, Wise CM. Rheumatoid arthritis: Review of psychological factors related to etiology, effects, and treatment. Psychological Bulletin 1985, 98:358-387.
16. Nicassio PM, Radojevic V, Weisman MH, Culbertson AL, Lewis C, Clemmey P. The role of helplessness in the response to disease modifying drugs in rheumatoid arthritis. J Rheumatol 1993, 20:1114-1120.
17. Callahan LF, Cordray DS, Wells G, Pincus T. Formal education and five-year mortality in rheumatoid arthritis: mediation by helplessness scale score. Arthritis Care Res 1996, 9:463-472. 10.1002/art.1790090608, 9136290.
18. Lorig K, Holman H. Arthritis self-management studies: a twelve-year review. Health Educ Q 1993, 20:17-28. 10.1177/109019819302000104, 8444622.
19. Petrides KV, Pita R, Kokkinaki F. The location of trait emotional intelligence in personality factor space. Br J Psychol 2007, 98:273-289. 10.1348/000712606X120618, 17456273.
20. Costa S, Petrides KV, Tillmann T. Trait emotional intelligence and inflammatory diseases. Psychol Health Med 2013, Revision under review.
21. Weyand CM, Klimiuk PA, Goronzy JJ. Heterogeneity of rheumatoid arthritis: from phenotypes to genotypes. Springer Semin Immunopathol 1998, 20:5-22. 10.1007/BF00831996, 9836366.
22. Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994, 91:8562-8566. 10.1073/pnas.91.18.8562, 44646, 8078923.
23. Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003, 48:2741-2749. 10.1002/art.11223, 14558078.
24. van der Pouw Kraan TC, van Gaalen FA, Huizinga TW, Pieterman E, Breedveld FC, Verweij CL. Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair. Genes Immun 2003, 4:187-196. 10.1038/sj.gene.6363975, 12700593.
25. Solomon GF, Moos RH. The relationship of personality to the presence of rheumatoid factor in asymptomatic relatives of patients with rheumatoid arthritis. Psychosom Med 1965, 27:350-360.
26. Vollhardt BR, Ackerman SH, Grayzel AI, Barland P. Psychologically distinguishable groups of rheumatoid arthritis patients: a controlled, single blind study. Psychosom Med 1982, 44:353-362.
27. Moos RH. Personality factors associated with rheumatoid arthritis: a review. J Chron Dis 1964, 17:41-55. 10.1016/0021-9681(64)90038-4, 14107169.
28. Margaretten M, Julian L, Katz P, Yelin E. Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int J Clin Rheumtol 2011, 6:617-623. 10.2217/ijr.11.62, 3247620, 22211138.
29. Katz PP, Yelin EH. Activity loss and the onset of depressive symptoms: do some activities matter more than others?. Arthritis Rheum 2001, 44:1194-1202. 10.1002/1529-0131(200105)44:5<1194::AID-ANR203>3.0.CO;2-6, 11352254.
30. Kojima M, Kojima T, Suzuki S, Oguchi T, Oba M, Tsuchiya H, Sugiura F, Kanayama Y, Furukawa TA, Tokudome S, Ishiguro N. Depression, inflammation, and pain in patients with rheumatoid arthritis. Arthritis Rheum 2009, 61:1018-1024. 10.1002/art.24647, 19644894.
31. Low CA, Cunningham AL, Kao AH, Krishnaswami S, Kuller LH, Wasko MC. Association between C-reactive protein and depressive symptoms in women with rheumatoid arthritis. Biol Psychol 2009, 81:131-134. 10.1016/j.biopsycho.2009.02.003, 2680764, 19428978.
32. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006, 27:24-31. 10.1016/j.it.2005.11.006, 3392963, 16316783.
33. Müller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Müller B, Spellmann I, Hetzel G, Maino K, Kleindienst N, Möller HJ, Arolt V, Riedel M. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 2006, 11:680-684. 10.1038/sj.mp.4001805, 16491133.
34. Mendlewicz J, Kriwin P, Oswald P, Souery D, Alboni S, Brunello N. Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study. Int Clin Psychopharmacol 2006, 21:227-231. 10.1097/00004850-200607000-00005, 16687994.
35. Hider SL, Tanveer W, Brownfield A, Mattey DL, Packham JC. Depression in RA patients treated with anti-TNF is common and under-recognized in the rheumatology clinic. Rheumatology 2009, 48:1152-1154. 10.1093/rheumatology/kep170, 19608723.
36. Parker JC, Smarr KL, Buckelew SP, Stucky-Ropp RC, Hewett JE, Johnson JC, Wright GE, Irvin WS, Walker SE. Effects of stress management on clinical outcomes in rheumatoid arthritis. Arthritis Rheum 1995, 38:1807-1818. 10.1002/art.1780381214, 8849353.
37. Rhee SH, Parker JC, Smarr KL, Petroski GF, Johnson JC, Hewett JE, Wright GE, Multon KD, Walker SE. Stress management in rheumatoid arthritis: what is the underlying mechanism?. Arthritis Care Res 2000, 13:435-442. 10.1002/1529-0131(200012)13:6<435::AID-ART15>3.0.CO;2-J, 14635321.
38. Zautra AJ, Davis MC, Reich JW, Nicassario P, Tennen H, Finan P, Kratz A, Parrish B, Irwin MR. Comparison of cognitive behavioral and mindfulness meditation interventions on adaptation to rheumatoid arthritis for patients with and without history of recurrent depression. J Consult Clin Psychol 2008, 76:408-421.
39. Petrides KV. Psychometric properties of the Trait Emotional Intelligence Questionnaire (TEIQue). Advances in the Measurement of Emotional Intelligence 2009, New York: Springer, Stough C.
40. Mikolajczak M, Luminet O, Leroy C, Roy E. Psychometric properties of the Trait Emotional Intelligence Questionnaire: factor structure, reliability, construct, and incremental validity in a French-speaking population. J Pers Assess 2007, 88:338-353. 10.1080/00223890701333431, 17518555.
41. Halliday JL. Psychological aspects of rheumatoid arthritis. Proc R Soc Med 1942, 35:455-457. 1998235, 19992524.
42. Cleveland SE, Fisher S. Behavior and unconscious fantasies of patients with rheumatoid arthritis. Psychosom Med 1954, 16:327-333.
43. Creed F. Psychological disorders in rheumatoid arthritis: a growing consensus?. Ann Rheum Dis 1990, 49:808-812. 10.1136/ard.49.10.808, 1004240, 2241274.
44. Mueller AD, Lefkovits AM. Personality structure and dynamics of patients with rheumatoid arthritis. J Clin Psychol 1956, 12:143-147. 10.1002/1097-4679(195604)12:2<143::AID-JCLP2270120208>3.0.CO;2-X, 13306806.
45. Hamilton NA, Zautra AJ, Reich J. Individual differences in emotional processing and reactivity to pain among older women with rheumatoid arthritis. Clin J Pain 2007, 23:165-172. 10.1097/AJP.0b013e31802b4f58, 17237666.
46. Lowman EW, Miller S, Lee PR, Stein H, King R, Heald L. Psychosocial factors in rehabilitation of the chronic rheumatic arthritic. Ann Rheum Dis 1954, 13:312-316. 10.1136/ard.13.4.312, 1006756, 13229239.
47. Shochet BR, Lisansky ET, Schubart AF, Fiocco V, Kurland S, Pope M. A medical - psychiatric study of patients with rheumatoid arthritis. Psychosomatics 1969, 10:271-279.
48. Terracciano A, Costa PT, McCrae RR. Personality plasticity after age 30. Pers Soc Psychol B 2006, 32:999-1099.
49. Sutin AR, Costa PT, Wethington E, Eaton W. Turning points and lessons learned: stressful life events and personality trait development across middle adulthood. Psychol Aging 2010, 25:524-533.
50. Specht J, Egloff B, Schmukle SC. Stability and change of personality across the life course: the impact of age and major life events on mean-level and rank-order stability of the Big Five. J Pers Soc Psychol 2011, 101:862-882.
51. Leuner B, Gould E. Dendritic growth in medial prefrontal cortex and cognitive flexibility are enhanced during the postpartum period. J Neurosci 2010, 30:13499-13503. 10.1523/JNEUROSCI.3388-10.2010, 2963448, 20926675.
52. Sternberg EM, Silverman MN, Cizza G. The neuroendocrine system and rheumatoid arthritis: insights from anti-tumor necrosis factor-alpha therapy. J Rheumatol 2007, 34:1443-1445.
53. Silverman MN, Sternberg EM. Neuroendocrine-immune interactions in rheumatoid arthritis: mechanisms of glucocorticoid resistance. Neuroimmunomodulation 2008, 15:19-28. 2920141, 18667796.
54. Imrich R. The role of neuroendocrine system in the pathogenesis of rheumatic diseases (minireview). Endocr Regul 2002, 36:95-106.
55. Knittle K, Maes S, de Gucht V. Psychological interventions for rheumatoid arthritis: examining the role of self-regulation with a systematic review and meta-analysis of randomized controlled trials. Arthritis Care Res (Hoboken) 2010, 62:1460-1472.
56. Simon GE, VonKorff M, Ustun TB, Gater R, Gureje O, Sartorius N. Is the lifetime risk of depression actually increasing?. J Clin Epidemiol 1995, 48:1109-1118. 10.1016/0895-4356(95)00010-2, 7636512.
57. Wright GE, Parker JC, Smarr KL, Schoenfeld-Smith K, Buckelew SP, Slaughter JR, Johnson JC, Hewett JE. Risk factors for depression in rheumatoid arthritis. Arthritis Care Res 1996, 9:264-272. 10.1002/1529-0131(199608)9:4<264::AID-ANR1790090411>3.0.CO;2-K, 8997915.
58. Gardiner BM. Psychological aspects of rheumatoid arthritis. Psychol Med 1980, 10:159-163. 10.1017/S0033291700039702, 7384318.
59. Crown S, Crown JM, Fleming A. Aspects of the psychology and epidemiology of rheumatoid disease. Psychol Med 1975, 5:291-299. 10.1017/S0033291700056671, 1080569.
60. Ellman P, Mitchell SD. The psychological aspects of chronic rheumatic joint disease. Reports on Chronic Rheumatic Diseases: Being the Annual Report of the British Committee on Chronic Rheumatic Diseases Appointed by the Royal College of Physicians, Volume 2 1936, 2:109. New York: Macmillan Company, Buckley CW.
61. Oreskes I, Rosenblatt S, Spiera H, Meadow H. Rheumatoid factors in an acute psychiatric population. Ann Rheum Dis 1968, 27:60-63. 10.1136/ard.27.1.60, 1031049, 5640844.
62. van der Linden MP, Batstra MR, Bakker-Jonges LE, , Detert J, Bastian H, Scherer HU, Toes RE, Burmester GR, Mjaavatten MD, Kvien TK, Huizinga TW, van der Helm-van Mil AH. Foundation for Quality Medical Laboratory Diagnostics Toward a data-driven evaluation of the 2010 American College of Rheumatology/European League Against Rheumatism criteria for rheumatoid arthritis: is it sensible to look at levels of rheumatoid factor?. Arthritis Rheum 2011, 63:1190-1199. 10.1002/art.30200, 21538311, Foundation for Quality Medical Laboratory Diagnostics.
63. Rimón R. Rheumatoid factor and aggression dynamics in female patients with rheumatoid arthritis. Scand J Rheumatol 1973, 2:119-122. 10.3109/03009747309098829, 4769064.
64. Wetherell MA, Byrne-Davis L, Dieppe P, Donovan J, Brookes S, Byron M, Vedhara K, Horne R, Weinman J, Miles J. Effects of emotional disclosure on psychological and physiological outcomes in patients with rheumatoid arthritis: an exploratory home-based study. J Health Psychol 2005, 10:277-285. 10.1177/1359105305049778, 15723896.
65. Smyth JM, Stone AA, Hurewitz A, Kaell A. Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis: a randomized trial. JAMA 1999, 281:1304-1309. 10.1001/jama.281.14.1304, 10208146.
66. Booth RJ, Petrie KJ, Pennebaker JW. Changes in circulating lymphocyte numbers following emotional disclosure: evidence of buffering?. Stress Med 1997, 13:23-29.
67. Pennebaker JW. Confession, inhibition and disease. Adv Exp Soc Psychol 1989, 22:211-244.
68. Moos RH, Solomon GF. Personality correlates of the rapidity of progression of rheumatoid arthritis. Ann Rheum Dis 1964, 23:145-151. 10.1136/ard.23.2.145, 1010359, 14130035.
69. Klareskog L, Padyukov L, Lorentzen J, Alfredsson L. Mechanisms of disease: genetic susceptibility and environmental triggers in the development of rheumatoid arthritis. Nat Rev Rheum 2006, 2:425-433.
70. Liao KP, Alfredsson L, Karlson EW. Environmental influences on risk for rheumatoid arthritis. Curr Opin Rheumatol 2009, 21:279-283. 10.1097/BOR.0b013e32832a2e16, 2898190, 19318947.
71. Mattey DL, Dawes PT, Clarke S, Fisher J, Brownfield A, Thomson W, Hajeer AH, Ollier WE. Relationship among the HLA-DRB1 shared epitope, smoking, and rheumatoid factor production in rheumatoid arthritis. Arthritis Care Res 2002, 47:403-407.
72. Ha E, Choe B-K, Jung KH, Yoon SH, Park HJ, Park HK, Yim SV, Chung JH, Bae HS, Nam M, Baik HH, Hong SJ. Positive relationship between melatonin receptor type 1B polymorphism and rheumatoid factor in rheumatoid arthritis patients in the Korean population. J Pineal Res 2005, 39:201-205. 10.1111/j.1600-079X.2005.00237.x, 16098099.
73. Sandhu V, Allen S. The effects of age, seropositivity and disease duration on autonomic cardiovascular reflexes in patients with rheumatoid arthritis. Int J Clin Practice 2004, 58:740-745.
74. Tak PP, Spaeny-Dekking L, Kraan MC, Breedveld FC, Froelich CJ, Hack CE. The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA). Clin Exp Immunol 1999, 116:366-370. 10.1046/j.1365-2249.1999.00881.x, 1905268, 10337032.
75. Pullerits R, Bokarewa M, Dahlberg L, Tarkowski A. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res Ther 2005, 7:R817-824. 10.1186/ar1749, 1175032, 15987483.
76. Hein GE, Köhler M, Oelzner P, Stein G, Franke S. The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis. Rheumatol Int 2005, 26:137-141. 10.1007/s00296-004-0518-1, 15580352.
77. Bobbio-Pallavicini F, Caporali R, Alpini C, Avalle S, Epis OM, Klersy C, Montecucco C. High IgA rheumatoid factor levels are associated with poor clinical response to tumour necrosis factor α inhibitors in rheumatoid arthritis. Ann Rheum Dis 2007, 66:302-307. 10.1136/ard.2006.060608, 1856018, 17079248.
78. Gao X, Fernandez-Vina M, Olsen NJ, Pincus T, Stastny P. HLA-DPB1*0301 is a major risk factor for rheumatoid factor-negative adult rheumatoid arthritis. Arthritis Rheum 1991, 34:1310-1312. 10.1002/art.1780341016, 1930320.
79. Runstadler JA, Säilä H, Savolainen A, Leirisalo-Repo M, Aho K, Tuomilehto-Wolf E, Tuomilehto J, Seldin MF. Association of SLC11A1 (NRAMP1) with persistent oligoarticular and polyarticular rheumatoid factor-negative juvenile idiopathic arthritis in Finnish patients: haplotype analysis in Finnish families. Arthritis Rheum 2005, 52:247-256. 10.1002/art.20772, 15641099.
80. Nasrallah NS, Masi AT, Chandler RW, Feigenbaum SL, Kaplan SB. HLA-B27 antigen and rheumatoid factor negative (seronegative) peripheral arthritis: studies in younger patients with early-diagnosed arthritis. Am J Med 1977, 63:379-386. 10.1016/0002-9343(77)90276-5, 900142.
81. Bhatia SS, Majka DS, Kittelson JM, Parrish LA, Ferucci ED, Deane KD, Arend WP, Rewers M, Michael Holers V, Norris JM. Rheumatoid factor seropositivity is inversely associated with oral contraceptive use in women without rheumatoid arthritis. Ann Rheum Dis 2007, 66:267-269. 1798510, 16868018.
82. Saxena N, Aggarwal A, Misra R. Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis. J Rheumatol 2005, 32:1349-1353.
83. Möttönen T, Paimela L, Leirisalo-Repo M, Kautiainen H, Ilonen J, Hannonen P. Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategy. Ann Rheum Dis 1998, 57:533-539. 10.1136/ard.57.9.533, 1752741, 9849312.